Healthy Women
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programTranscranial Magnetic Stimulation ActiveN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
EvestraEVE119 vaginal ring
City TherapeuticsTranscranial Magnetic Stimulation Active
Clinical Trials (2)
Total enrollment: 36 patients across 2 trials
Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring
Start: Jul 2023Est. completion: Dec 202336 patients
Phase 1Completed
TMS-Induced LH Response in Healthy Women in Luteal Phase
Start: Feb 2026Est. completion: Jun 2026
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 36 patients
2 companies competing in this space